NCT06198426
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06198426
Title A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Scientia Clinical Research Ltd Randwick New South Wales 2770 Australia Details
Liverpool Hospital Sydney New South Wales 2170 Australia Details
Westmead Hospital Sydney New South Wales 2170 Australia Details
Jiang Su Province Hospital Nanjing Jiangsu 210024 China Details
The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang 310009 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field